Treatment of psoriasis with fumaric acid esters (Fumaderm). (Q34656799)

3 August 2017

title

Treatment of psoriasis with fumaric acid esters (Fumaderm). (English)

1 reference

3 August 2017

Ulrich Mrowietz

1

1 reference

3 August 2017

Peter Altmeyer

2

1 reference

3 August 2017

Thomas Bieber

3

1 reference

3 August 2017

Martin Röcken

4

1 reference

3 August 2017

Rudolf E Schopf

5

1 reference

3 August 2017

Wolfram Sterry

6

1 reference

3 August 2017

publication date

1 August 2007

1 reference

3 August 2017

1 reference

3 August 2017

volume

5

1 reference

3 August 2017

issue

8

1 reference

3 August 2017

page(s)

716-717

1 reference

[Efficacy and safety profile of fumaric acid esters in oral long-term therapy with severe treatment refractory psoriasis vulgaris. A study of 83 patients].

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111/J.1610-0387.2007.06346.X

Long-term safety aspects of systemic therapy with fumaric acid esters in severe psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1610-0387.2007.06346.X

Topical calcipotriol plus oral fumaric acid is more effective and faster acting than oral fumaric acid monotherapy in the treatment of severe chronic plaque psoriasis vulgaris

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1610-0387.2007.06346.X

[S3-Guidelines for the therapy of psoriasis vulgaris].

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1610-0387.2007.06346.X

10.1111/J.1610-0387.2007.06346.X

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference